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via ARF6-mediated trafficking to the plasma membraneAmplifying Btk’s Signal
(Honda et al., 1999), relatively little is known about PIP5K
activation in lymphocytes. New data from Carpenter and
colleagues suggest that the Tec kinase Btk is a key
player in this process (Figure 1) (Saito et al., 2003).
The Tec family of nonreceptor tyrosine kinases are
The Tec kinase Btk is an important regulator of antigen notable for their amino-terminal pleckstrin homology do-
receptor activation of phospholipase C- (PLC-). mains, which bind to the products of PI3K, and PI3K
Data from Carpenter and colleagues (Saito et al., 2003, activity is required for their function (reviewed in Schaef-
this issue of Immunity) now suggest that Btk also fer and Schwartzberg, 2000). Mutations affecting Btk
activates phosphatidylinositol-4-phosphate 5-kinase
cause the human immunodeficiency X-linked agamma-
(PIP5K), thereby stimulating a positive feedback loop
globulinemia (XLA) and the mouse mutant X-linked im-
that generates PI(4,5)P2, the substrate for both phos- munodeficiency, which are associated with impaired
phoinositide 3-kinase (PI3K) and PLC-.
responses to B cell receptor engagement. Studies of Btk-
deficient cells revealed that Btk is an important regulator
of antigen-receptor-induced Ca2 mobilization (Fluck-Phosphoinositides are critical intermediates that regu-
iger et al., 1998; Takata and Kurosaki, 1996). Cells lack-late many cellular processes including cell survival,
ing Btk show defects in sustained Ca2 influx, which aregrowth and proliferation, Ca2 mobilization, membrane
associated with decreased phosphorylation of PLC-trafficking, cytoskeletal rorganization, and migration
and impaired IP3 production. Tec kinases have also been(Takenawa and Itoh, 2001). PI3K, which generates phos-
implicated in similar roles downstream of the Fc recep-phatidylinositol-3,4,5-trisphosphate (PIP3), a phospho-
tor in mast cells and the T cell receptor in T lymphocytes.inositide that binds to and activates proteins containing
As a consequence, lymphocytes deficient in Tec kinasespleckstrin homology domains, is an important compo-
show decreased activation of multiple downstream read-nent of immunoreceptor signaling. Similarly, PLC-,
outs dependent on IP3 and DAG production, includingwhich generates inositol trisphosphate (IP3) and diacyl-
activation of transcription factors, MAP kinases, andglycerol (DAG), is a key activator of Ca2 mobilization
protein kinase C (Schaeffer and Schwartzberg, 2000).and PKC/Ras-mediated pathways. Both PI3K and PLC-
Although Btk has been implicated in the direct phos-share the common substrate, phosphoinositide 4,5 bis-
phorylation of PLC-, tyrosine phosphorylation of PLC-phosphate [PI(4,5)P2], the product of phosphatidylinosi-
can still be observed in lymphocytes deficient in Tectol-4-phosphate 5-kinase (PIP5K). PI(4,5)P2 is one of the
kinases, despite clear Ca2 defects (Fluckiger et al.,most highly abundant phosphoinositides, yet, in other
1998; Schaeffer and Schwartzberg, 2000). Thus, it re-systems, receptor activation can significantly decrease
mained unclear whether phosphorylation was the onlyPI(4,5)P2 levels. Replenishing PI(4,5)P2 levels should
mechanism by which Tec kinases regulate PLC- activ-therefore be important for sustaining receptor responses.
Although Rac has been implicated in activation of PIP5K ity. Moreover, overexpression of either wild-type or ki-
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Figure 1. Btk Stimulates a Positive Feedback Loop in Antigen Receptor Signaling by Activating PIP5K to Increase Generation of PI(4,5)P2,
the Substrate for Both PI3K and PLC-
nase-inactive Btk had been shown to increase PIP3 Such signal amplification could also contribute
to other pathways downstream of antigen receptors.levels and to partially rescue Ca2 mobilization in Btk-
deficient DT-40 cells, suggesting that Btk may have ki- PI(4,5)P2 itself plays important roles in actin cytoskeleton
organization—PI(4,5)P2 binds to and regulates a numbernase-independent functions in regulating phosphoinosi-
tide metabolism (Scharenberg et al., 1998; Tomlinson of actin regulatory proteins including profilin, gelsolin,
-actinin, and WASP, the Wiskott-Aldrich Syndromeet al., 2001).
The work of Saito and colleagues in this issue of Im- Protein, mutations of which disrupt the actin cytoskele-
ton in T cells and platelets (Takenawa and Itoh, 2001).munity helps clarify this role of Btk (Saito et al., 2003).
In this paper, the authors confirm that overexpression Intriguingly, recent data implicate Tec kinases as regula-
tors of actin cytoskeleton reorganization. Expression ofof Btk increases both Ca2 mobilization and PIP3 levels,
independent of Btk kinase activity. Speculating that Btk activated BTK, like localized activation of PIP5K by
ARF6, increases actin accumulation and membrane ruf-may affect phosphoinositide regulation, the authors
then show that PIP5K activity can be coimmunoprecipi- fling (Nore et al., 2000). Moreover, mutations affecting
the Tec kinase Itk impair TCR-driven actin reorganiza-tated with Btk and that overexpression of Btk or the
Btk-PH domain causes membrane localization of PIP5K, tion and cell polarization (Grasis et al., 2003; Labno et
al., 2003). Data suggest that Itk may affect actin polymer-similar to that induced by ARF6. A direct interaction
between the PH domain of Btk and PIP5K activity could ization in a kinase-independent manner, reminiscent
of the kinase-independent regulation of PIP5K by BTKbe detected. While most of the work utilized overexpres-
sion studies, Btk-deficient DT-40 cells exhibited de- (Grasis et al., 2003). Although it is not known whether
Itk can regulate PIP5K, it is interesting to speculate thatcreased PI(4,5)P2 levels upon antigen stimulation, sug-
gesting physiologically important roles for this process local recruitment of PIP5K to the site of antigen presen-
tation via interactions with Itk could contribute to T cell(Figure 1). Overexpression of both Btk and PIP5K pro-
longed BCR-induced Ca2 mobilization and increased polarization. Rac/ARF6 are also likely to play important
roles in this process, emphasizing the many layers ofPIP3 levels, arguing that, together, these molecules am-
plify signals in response to antigen receptor stimulation. positive-feedback that may occur in signaling pathways.
It is also intriguing to speculate that Tec kinases mayThe interaction between Btk and PIP5K has important
implications for establishing a positive regulatory loop participate in amplification loops in other pathways. In
chemokine signaling, stimulation of G protein-coupledin antigen receptor signaling. By activating PIP5K, Btk
creates more substrate both for PI3K, which is required receptors causes the localized activation of PI3K and
the rapid recruitment of proteins containing PIP3 bindingfor Btk activation, as well as for PLC-, which is a down-
stream effector of Btk. This leads to a particularly effi- PH domains to the leading edge of the polarized cell,
setting up a cellular compass for migration (Bourne andcient mode of signal amplification, by both increasing
Btk activation and providing more substrate for its tar- Weiner, 2002). This gradient of PIP3 and PH containing
proteins within the cell appears greater than the chemo-get. This amplification loop may account for the effect
of Tec kinases on the prolonged phase of capacitive kine gradient outside the cell, suggesting an internal
amplification loop. A positive-feedback loop that sup-Ca2 entry, which may be more dependent on continued
signal propagation. Indeed, T cells deficient in Tec ki- plies more substrate for PI3K could provide a mecha-
nism for such signal amplification. Indeed, evidence nownases have phenotypes resembling those resulting from
decreased signal duration (Schaeffer and Schwartzberg, suggests that Tec kinases participate in chemokine sig-
naling (Gilbert et al., 2003).2000). Decreased PI(4,5)P2 levels and reduced PI3K ac-
tivity may also account for decreased activation of Akt Btk’s roles in phosphoinositide signaling are likely to
be more complex than this paper suggests. Mutationsin Btk-deficient cells.
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